The Newsroom
Item 1 of 3
AdventHealth Research Institute Offers Phase II Clinical Trial of Etanercept for Treatment of Blast-Induced Tinnitus
Approximately 1 billion people throughout the world suffer from tinnitus (ringing in the ears), and it is the number one disability of those who serve in the U.S. military. The condition can disrupt...
Item 2 of 3
AdventHealth’s Karen D. Corbin, PhD, RD, Contributed to New American Diabetes Association Consensus Statement on Liver Disease in Diabetes
Item 3 of 3
AdventHealth East Orlando First in Florida to Earn Advanced Foot & Ankle Surgery Certification from DNV
Recent Stories at AdventHealthMD
-
-
Using Genomics and AI to Improve Breast Cancer Risk Assessment and Early Detection
-
New Research Published in New England Journal of Medicine Finds That Adjuvant Pembrolizumab Extends Disease-Free Survival in Muscle-Invasive Urothelial Carcinoma
-
AdventHealth Launches Research Study to Evaluate an Evidence-based Intervention Designed to Address Physician Burnout
-
New treatment for AFib patients shows less tissue damage and improved outcomes, offered first at AdventHealth
-
AdventHealth Physician Team Performs Central Florida’s First Immediate Breast Neurotization After Nipple-sparing Mastectomy
-
Harnessing Music’s Healing Power for Stroke Survivors in Central Florida
-
Chief Clinical Officer Appointed to Serve the AdventHealth East Florida Division
-
AdventHealth Involved in Research to Evaluate First Potential Disease-Modifying Treatment for Epileptic Patients with Dravet Syndrome